This compound is primarily used in the development of pharmaceutical agents, particularly in the field of central nervous system (CNS) research. It serves as a key intermediate in the synthesis of compounds that target neurotransmitter systems, potentially aiding in the treatment of neurological disorders such as depression, anxiety, and schizophrenia. Its structural features make it suitable for binding to specific receptors in the brain, which can modulate the activity of neurotransmitters like serotonin and dopamine. Additionally, it is explored in the design of drugs for pain management and cognitive enhancement, owing to its ability to interact with various neural pathways. Researchers also investigate its potential in creating novel therapeutic agents for neurodegenerative diseases like Alzheimer's and Parkinson's.